These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38505869)

  • 1. microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB.
    Sun G; Ni K; Shen J; Liu D; Wang H
    Crit Rev Eukaryot Gene Expr; 2024; 34(4):13-23. PubMed ID: 38505869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-195-5p inhibits cisplatin resistance in lung adenocarcinoma by regulating DNA damage via targeting E2F7.
    Wu H; Zheng B
    J Biochem Mol Toxicol; 2024 Nov; 38(11):e70015. PubMed ID: 39415701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Regulation of let-7c-5p on the Biological Characteristics of Lung Adenocarcinoma Cells by Targeting AURKB.
    Wang L; Xiao X; Du H
    Mol Biotechnol; 2022 May; 64(5):526-534. PubMed ID: 34997902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
    Han J; Wang Y
    Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7c-5p Represses Cisplatin Resistance of Lung Adenocarcinoma Cells by Targeting CDC25A.
    Huang L; Lou K; Wang K; Liang L; Chen Y; Zhang J
    Appl Biochem Biotechnol; 2023 Mar; 195(3):1644-1655. PubMed ID: 36355336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.
    Zhou Y; Yan J; Chen H; Zhou W; Yang J
    Cells Tissues Organs; 2024; 213(1):55-66. PubMed ID: 36273455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
    Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
    Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription Factor E2F8 Activates PDK1-Mediated DNA Damage Repair to Enhance Cisplatin Resistance in Lung Adenocarcinoma.
    Li H; Sun J; Hu H; Wang Y
    Pharmacology; 2024; 109(6):341-356. PubMed ID: 38810606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma.
    Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W
    Electrophoresis; 2024 Aug; 45(15-16):1408-1417. PubMed ID: 38629299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
    Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
    Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
    Xu J
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):721-731. PubMed ID: 37989335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
    Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
    Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-9-5p Facilitates Lung Adenocarcinoma Cell Malignant Progression via Targeting STARD13.
    Lu Y; Zheng W; Rao X; Du Y; Xue J
    Biochem Genet; 2022 Dec; 60(6):1865-1880. PubMed ID: 35119587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
    Liu B; Wang R; Liu H
    Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
    Du H; Li Y; Sun R; Yuan Y; Sun S; Zhang Y
    Thorac Cancer; 2020 Sep; 11(9):2473-2482. PubMed ID: 32648688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis.
    Yu N; Gong H; Chen W; Peng W
    Thorac Cancer; 2023 Jun; 14(16):1467-1476. PubMed ID: 37105934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
    Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
    Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.
    Li J; He X; Wu X; Liu X; Huang Y; Gong Y
    Comput Math Methods Med; 2020; 2020():2953598. PubMed ID: 33204298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.